Small, dense, low-density lipoprotein and atherosclerosis (Q43921249)

28 November 2017

Small, dense, low-density lipoprotein and atherosclerosis (English)

1 reference

28 November 2017

1 reference

H R Superko

1

1 reference

28 November 2017

1 May 2000

1 reference

Current Atherosclerosis Reports

28 November 2017

1 reference

28 November 2017

2

1 reference

28 November 2017

3

1 reference

28 November 2017

226-231

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-000-0024-1

28 November 2017

0 references

cites work

Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0024-1

Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0024-1

Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0024-1

Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0024-1

LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0024-1

Did grandma give you heart disease? The new battle against coronary artery disease

21 January 2018

1 reference

12 December 2020

Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density

1 reference

12 December 2020

Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men.

1 reference

12 December 2020

Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia.

1 reference

12 December 2020

Comparison of electron beam computed tomography scanning and conventional risk factor assessment for the prediction of angiographic coronary artery disease.

1 reference

12 December 2020

Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a).

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

The role of lipids and lipoproteins in atherosclerosis.

1 reference

12 December 2020

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

12 December 2020

Inclusion of lipoprotein subfractions among efficacy parameters.

1 reference

12 December 2020

Effect of gemfibrozil treatment in hypercholesterolemia on low density lipoprotein (LDL) subclass distribution and LDL-cell interaction

1 reference

12 December 2020

Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)

1 reference

12 December 2020

Differential effects of nicotinic acid in subjects with different LDL subclass patterns

1 reference

12 December 2020

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk

1 reference

12 December 2020

Effect of fluvastatin on low-density lipoprotein peak particle diameter.

1 reference

12 December 2020

10.1007/S11883-000-0024-1

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

11122748